AstraZeneca Pharma India Share Price Gains Over 2%; Signs LOI with Strand Life Sciences for Healthcare Collaboration

AstraZeneca Pharma India Limited announced on November 17, 2026, that it has signed a Letter of Intent (LoI) with Strand Life Sciences Private Limited to explore collaboration opportunities in the Indian healthcare sector.
The regulatory disclosure was filed with both BSE Limited and the National Stock Exchange of India Limited.
Key Details of the Letter of Intent
Under the terms of the Letter of Intent, AstraZeneca Pharma India Limited and Strand Life Sciences Private Limited will evaluate potential areas of partnership across healthcare in India. Strand Life Sciences Private Limited operates as a genomics research and diagnostics company and is a subsidiary of Reliance Industries Limited.
The company confirmed in its exchange filing that AstraZeneca Pharma India Limited and Strand Life Sciences Private Limited are not related parties. Consequently, the execution of the Letter of Intent does not constitute a related party transaction.
Corporate Disclosures and Company Background
Information regarding the partnership has also been shared through AstraZeneca India's official LinkedIn handle and published on the company's corporate website. The regulatory filing was signed by Tanya Sanish, Company Secretary and Compliance Officer of AstraZeneca Pharma India Limited.
Headquartered in Bengaluru, Karnataka, AstraZeneca Pharma India Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines across key therapeutic areas in India.
AstraZeneca Pharma India Share Price Performance
As of November 17, 2026, at 2:33 PM, AstraZeneca Pharma India share price on NSE was trading at ₹6,156.00, up by 2.04% from the previous closing price.
Conclusion
On November 17, 2026, AstraZeneca Pharma India Limited entered into a non-related party Letter of Intent with Reliance Industries subsidiary Strand Life Sciences Private Limited to explore healthcare collaboration opportunities in India.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 17, 2026, 3:39 PM IST

Team Angel One
- Indian Oil Corporation Gets Government Approval to Supply Sustainable Aviation Fuel
- Top Gainers and Losers on November 17, 2026: Adani Enterprises and Eicher Motors Gain, While HCLTech Drops Over 2%
- NIFTY 50 Index Climbs Above 25,400 Mark in Intraday Trade on November 17, 2026; Recovers Previous Losses Triggered by US-Iran Conflict
- JSW Motors Prepares First Plug-in Hybrid SUV with Over 50 Global and Indian Partners
- Tata Group Stocks Rally Up to 9% After RBI Reiterates Tata Sons Listing Mandate




